Natasha Deckmann - 20 May 2026 Form 4 Insider Report for Option Care Health, Inc. (OPCH)

Reporting relationship: Director
Issuer ticker: OPCH
Reported as of: 20 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 May 2026, 18:08:04 UTC
Prior SEC filing: 19 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael Bavaro, attorney-in-fact for Ms. Deckmann

Key filing fact

Natasha Deckmann filed Form 4 for Option Care Health, Inc. (OPCH) on 22 May 2026.

Key facts

This page summarizes Natasha Deckmann's Form 4 filing for Option Care Health, Inc. (OPCH).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 22 May 2026, 18:08.

Change

Previous filing in this sequence was filed on 19 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001902330 Primary reporting owner

Deckmann Natasha

Relationship: Director
Address: C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN
Signature: /s/ Michael Bavaro, attorney-in-fact for Ms. Deckmann
Signature date: 22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OPCH transaction

Common Stock

Award

Transaction value
Shares: +8,997
Change %: +41%
Price: $0.000000^*
Shares after: 31,158
Date: 20 May 2026
Ownership: Direct
Footnotes: F1

OPCH transaction

Common Stock

Award

Transaction value
Shares: +844
Change %: +2.7%
Price: $22.23^*
Shares after: 32,002
Date: 20 May 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

Footnote F2

The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.